Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. Its discovery, development, and manufacturing teams are using cutting-edge technology to create and develop products to address unmet medical needs.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 13, 2000 | Series Unknown | $40.50M | 2 | — | — | Detail |
May 17, 1999 | Series Unknown | $2M | 1 | BankInvest Biomedical Venture | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
LODH Immunology Fund | — | Series Unknown |
BankInvest Biomedical Venture | — | Series Unknown |